Daiichi exploring legal options against Ranbaxy's former promo...

Dinesh Thakur, the Ranbaxy whistleblower, says he have no basis to comment on Daiichi Sankyo's decision to sue the Singh family for concealment and misrepresentation of data, as he left the company in 2005.

Daiichi Sankyo, the Japanese parent of Ranbaxy Laboratories, today said it believes that certain shareholders of the Indian company concealed and misrepresented critical information. The company is now pursuing legal remedies. “Daiichi Sankyo believes ...

Following the news, shares of the company opened the day on a weak note and further tanked 9.3 per cent to Rs 391 on the BSE. At NSE, the stock tumbled 9.37 per cent to Rs 390.65. Following the weakness in the stock, the market value of the company slipped by ...

Smarting from its $500 million fine from the US Food and Drug Administration (FDA) last week, Japan's Daiichi Sankyo, the current promoter of Ranbaxy Laboratories, indicated on Wednesday that it might take legal recourse against the Indian generic ...

ArQule, Inc., a clinical-stage biotechnology company, has regained worldwide rights for the development and commercialization of compounds covered under its AKT collaboration with Daiichi Sankyo Co., Ltd., including the lead compound emerging from ...

SWOT Analysis, is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective of the business venture or project and ...

--Astellas logged 5.9% growth in net profit for fiscal year ended March, but result falls short of company's, analysts' forecasts --Daiichi Sankyo returns to profit in fiscal fourth quarter, posts six-fold jump in annual net profit --Both firms ...

Daiichi Sankyo Company, Limited has received approval from Japan's Ministry of Health, Labour and Welfare to manufacture and market the osteoporosis treatment PRALIA subcutaneous injection 60mg syringe for the treatment of osteoporosis. PRALIA is a ...

Daiichi Sankyo made the announcement on Wednesday, 22 May 2013. Meanwhile, the BSE Sensex was down 345.63 points, or 1.72%, to 19,716.61. On BSE, 3.47 shares were traded in the counter as against an average daily volume of 1.34 lakh shares in the past one ...